Reglan: Effective Relief for Gastroparesis and Severe Heartburn
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.39 | $35.26 (0%) | 🛒 Add to cart |
| 120 | $0.37 | $47.01 $43.86 (7%) | 🛒 Add to cart |
| 180 | $0.34 | $70.52 $61.06 (13%) | 🛒 Add to cart |
| 270 | $0.32 | $105.78 $87.72 (17%) | 🛒 Add to cart |
| 360 | $0.32
Best per pill | $141.04 $113.52 (20%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Reglan (metoclopramide hydrochloride) is a prescription medication indicated for the short-term treatment of adults with diabetic gastroparesis and for the relief of symptoms associated with gastroesophageal reflux disease (GERD) when conventional therapy has proven inadequate. As a dopamine antagonist and prokinetic agent, it works by increasing the contractions of the upper gastrointestinal tract, accelerating gastric emptying, and strengthening the lower esophageal sphincter. This action provides targeted relief from debilitating symptoms like chronic nausea, vomiting, and persistent heartburn, helping restore digestive normalcy and improve quality of life.
Features
- Active Ingredient: Metoclopramide Hydrochloride
- Available Forms: Oral tablets (5 mg, 10 mg), oral solution, and injectable formulation
- Mechanism of Action: Dopamine D2 receptor antagonist and 5-HT4 receptor agonist
- Onset of Action: Oral administration typically shows effects within 30-60 minutes
- Duration of Effect: Therapeutic action generally lasts 1-2 hours per dose
- Prescription Status: Available only with a valid physician’s prescription
Benefits
- Accelerates gastric emptying, providing relief from the delayed stomach emptying characteristic of gastroparesis
- Reduces the frequency and severity of nausea and vomiting episodes
- Decreases reflux symptoms by strengthening the lower esophageal sphincter tone
- Improves overall quality of life by enabling better nutritional intake and medication absorption
- Offers flexible administration options including oral and injectable formulations for different clinical scenarios
- Provides relatively rapid symptomatic relief compared to some other gastrointestinal agents
Common use
Reglan is primarily prescribed for two main indications. First, for the short-term (4-12 weeks) management of symptomatic diabetic gastroparesis in adults, which manifests as postprandial fullness, early satiety, nausea, vomiting, and bloating due to delayed gastric emptying. Second, as therapy for severe, refractory gastroesophageal reflux disease that has not responded adequately to conventional treatments like proton pump inhibitors or H2 receptor antagonists. It may also be used off-label in certain clinical situations, such as preventing postoperative nausea and vomiting or facilitating small bowel intubation, though these uses require careful physician evaluation.
Dosage and direction
For diabetic gastroparesis in adults: 10 mg administered 30 minutes before each meal and at bedtime, typically for 4-12 weeks depending on therapeutic response and tolerability. For GERD: 10-15 mg up to four times daily 30 minutes before meals and at bedtime. The maximum recommended duration of treatment is 12 weeks due to the risk of tardive dyskinesia with longer use. Dosage should be reduced in patients with renal impairment (CrCl <40 mL/min) and hepatic impairment. Tablets should be swallowed whole with water; the oral solution should be measured precisely using the provided dosing device. Always follow the specific dosing instructions provided by the prescribing physician.
Precautions
Use with caution in patients with depression, Parkinson’s disease, or hypertension. May cause drowsiness or dizziness; patients should avoid driving or operating machinery until they know how Reglan affects them. Alcohol may enhance certain nervous system effects and should be avoided. Not recommended for use in children except in specific emergency situations under close medical supervision. Elderly patients may be more sensitive to the effects of Reglan, particularly extrapyramidal symptoms. Patients should be monitored for signs of depression or suicidal ideation. Regular assessment for movement disorders is essential, especially with prolonged use.
Contraindications
Hypersensitivity to metoclopramide or any component of the formulation. Concomitant use with drugs that are likely to cause extrapyramidal symptoms. Patients with pheochromocytoma due to risk of hypertensive crisis. Patients with gastrointestinal obstruction, perforation, or hemorrhage. Patients with epilepsy or those prone to seizures, as the drug may lower the seizure threshold. Should not be used in patients with a history of methemoglobinemia with metoclopramide or NADH cytochrome b5 reductase deficiency.
Possible side effect
Common side effects (≥1%) include: restlessness, drowsiness, fatigue, insomnia, headache, dizziness, nausea, diarrhea. Less frequent but more serious side effects may include: tardive dyskinesia (potentially irreversible involuntary movements of face and limbs), neuroleptic malignant syndrome (fever, muscle rigidity, altered mental status), depression, suicidal ideation, hyperprolactinemia (which may cause galactorrhea, amenorrhea, gynecomastia, or impotence), methemoglobinemia (particularly in neonates), and seizures. Extrapyramidal symptoms (muscle spasms, tremors, facial grimacing) may occur, particularly in children and young adults.
Drug interaction
Significant interactions may occur with: other drugs that cause drowsiness (CNS depressants including opioids, benzodiazepines, alcohol), antipsychotics (increased risk of extrapyramidal symptoms), MAO inhibitors (risk of hypertensive crisis), serotonergic drugs (increased risk of serotonin syndrome), drugs that prolong QT interval, levodopa and dopamine agonists (antagonistic effects), digoxin (may decrease absorption), cyclosporine (increased absorption), and succinylcholine (prolonged neuromuscular blockade). Always inform your healthcare provider of all medications you are taking, including prescription, over-the-counter, and herbal products.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. If multiple doses are missed or uncertainty exists about dosing, contact your healthcare provider for guidance. Maintaining consistent timing of doses relative to meals is important for optimal therapeutic effect.
Overdose
Symptoms of overdose may include drowsiness, disorientation, extrapyramidal symptoms, seizures, and cardiovascular effects. In cases of suspected overdose, seek immediate medical attention or contact a poison control center. Treatment is primarily supportive and symptomatic. There is no specific antidote. Activated charcoal may be administered if ingestion was recent. Extrapyramidal symptoms may be managed with diphenhydramine or benztropine. Close monitoring of cardiac and respiratory function is essential. Hemodialysis is not likely to be effective due to high protein binding and large volume of distribution.
Storage
Store at room temperature (20-25°C or 68-77°F) in the original container, protected from light and moisture. Keep the container tightly closed. Do not freeze the oral solution. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Properly discard any unused medication after treatment completion; do not flush down the toilet or pour down the drain unless instructed to do so. Consult your pharmacist about proper disposal methods.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting, changing, or stopping any medication. The content provided here is not exhaustive and may not include all possible information about this medication. Only a healthcare provider who knows your complete medical history can determine if this medication is appropriate for you. Never disregard professional medical advice or delay seeking it because of something you have read here.
Reviews
“After suffering with gastroparesis for years, Reglan gave me my life back. The nausea and vomiting decreased significantly within the first week of treatment. I did experience some restlessness initially, but this subsided after the first few doses.” - Sarah T., 42
“As a gastroenterologist, I find Reglan to be an effective option for short-term management of refractory gastroparesis. However, I strictly limit treatment duration to 8-12 weeks and monitor patients closely for any neurological side effects.” - Dr. M. Chen, MD
“The medication worked well for my severe reflux, but I developed mild hand tremors after 10 weeks of use. My doctor discontinued it immediately, and the tremors resolved within a few weeks. Effective but requires careful monitoring.” - James L., 58